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DiarrheaDeﬁciency of the phospholipidﬂippaseATPase, aminophospholipid transporter, class I, type 8B,member 1 (ATP8B1)
causes progressive familial intrahepatic cholestasis type 1 (PFIC1) andbenign recurrent intrahepatic cholestasis type
1 (BRIC1). Apart from cholestasis, many patients also suffer from diarrhea of yet unknown etiology. Here we have
studied the hypothesis that intestinal ATP8B1 deﬁciency results in bile salt malabsorption as a possible cause of
PFIC1/BRIC1 diarrhea.
Bile salt transportwas studied inATP8B1-depleted intestinal Caco-2 cells. Apicalmembrane localizationwas studied
by a biotinylation approach. Fecal bile salt and electrolyte contentswere analyzed in stool samples of PFIC1 patients,
of whom some had undergone biliary diversion or liver transplantation.
Bile salt uptake by the apical sodium-dependent bile salt transporter solute carrier family 10 (sodium/bile acid
cotransporter), member 2 (SLC10A2) was strongly impaired in ATP8B1-depleted Caco-2 cells. The reduced
SLC10A2 activity coincidedwith strongly reduced apicalmembrane localization,whichwas caused by impaired api-
calmembrane insertionof SLC10A2.Moreover,we show that endogenousATP8B1 exists in a functional heterodimer
with transmembrane protein 30A (CDC50A) in Caco-2 cells. Analyses of stool samples of post-transplant PFIC1 pa-
tients demonstrated that bile salt content was not changed, whereas sodium and chloride concentrations were ele-
vated and potassium levels were decreased.
The ATP8B1–CDC50A heterodimer is essential for the apical localization of SLC10A2 in Caco-2 cells. Diarrhea in
PFIC1/BRIC1 patients has a secretory origin towhich SLC10A2 deﬁciencymay contribute. This results in elevated lu-
minal bile salt concentrations and consequent enhanced electrolyte secretion and/or reduced electrolyte resorption.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign
recurrent intrahepatic cholestasis type 1 (BRIC1) are rare autosomal re-
cessive liver diseases caused by mutations in the gene encoding the P-
type ATPase ATP8B1 [1,2]. ATP8B1 is a P4 ATPase and is a phospholipid
ﬂippase that translocates phosphatidylserine from the exoplasmic to the
cytosolic leaﬂet of the plasma membrane [3,4]. ATP8B1 is expressed in
the apical membrane of many epithelial cell types, including hepato-
cytes, cholangiocytes and enterocytes [5,6]. In vitro studies have indi-
cated that ATP8B1 exists as a heterodimer with its β-subunit CDC50A;
heterodimerization is pivotal for endoplasmic reticulum (ER) exit and
for activity of the protein [3,7–9].ter, Tytgat Institute for Liver
Amsterdam, The Netherlands.
Mark).PFIC1 and BRIC1 patients present with jaundice and pruritus caused
by impaired bile ﬂow [10]. While BRIC1 patients suffer from intermit-
tent bouts of cholestasis and pruritus without liver scarring, PFIC1 pa-
tients have non-remitting and progressive liver disease leading to
ﬁbrosis and cirrhosis. Biliary diversion (BD) procedures relieve symp-
toms for BRIC1 and PFIC1 patients and generally sufﬁce as therapy for
hepatobiliary disease; however, formanyPFIC1 patients liver transplan-
tation (LTx) is the only curative therapy [11,12]. Extrahepatic symptoms
such as diarrhea and hearing loss are common in PFIC1 and BRIC1
patients [10,13,14]. After LTx, PFIC1 patients have a high risk (~85%) of
developing an exacerbated form of diarrhea, possibly as a consequence
of restored bile ﬂow [15–19]. Diarrhea is ameliorated upon treatment
with bile salt-absorptive resins such as cholesevelam and cholestyramine
[20]. Although the etiology of diarrhea in ATP8B1-deﬁcient patients is not
known, the observations in liver-transplanted patients allow the hypoth-
esis that intestinal bile saltmalabsorption is the cause of diarrhea in these
patients. In the intestine, approximately 95% of conjugated bile salts are
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SLC10A2), which is located in the apical membrane of enterocytes in the
terminal ileum [21]. Congenital ileal bile salt transport defects or ileal re-
section are usually associated with diarrhea. Indeed, mutations in
SLC10A2 are the cause of primary bile acid malabsorption, an intestinal
disorder associated with congenital diarrhea [22].
Here we have studied the hypothesis that diarrhea in ATP8B1 deﬁ-
ciency is caused by intestinal bile salt malabsorption. Bile salt transport
was studied in ATP8B1-depleted Caco-2 cells and fecal bile salt output
was analyzed in PFIC1 patients, of whom some had undergone BD or
LTx.
2. Materials and methods
2.1. Antibodies and reagents
Primary antibodies: rabbit polyclonals to SLC10A2 (kindly provided
by Dr. P.A. Dawson) [23], CDC50A [24], ATP8B1 [25], ATP1A1 [26], CD13
(H-300, Santa Cruz Biotechnology), CD26 (A28340, Abcam), and
SLC2A2 (07–1402, Millipore), and mouse monoclonals to calnexin
(H-70, Santa Cruz Biotechnology), P-glycoprotein (C219, Abcam),
ABCC2 (M2III6) [27], and villin (MAB1671, Millipore). Dimerized bile-
salt SLC10A2-speciﬁc inhibitor S910960 (Aventis) [28]. All other, non-
speciﬁed chemicals and reagents were obtained from Sigma-Aldrich.
2.2. Cell culture and lentiviral transduction
The human colonic adenocarcinoma Caco-2 cell line (ATCC, HTB-37)
was cultured in Dubecco's Modiﬁed Eagle Medium (DMEM; Lonza)
supplemented with 10% bovine fetal calf serum, 2 mM L-glutamine,
100 U/ml penicillin, and 100 U/ml streptomycin at 37 °C in a 10% CO2
humidiﬁed atmosphere. Culture medium was refreshed twice per
week. Stable knockdown cell lines were generated by lentiviral trans-
duction with shRNA vectors from the Mission shRNA library (Sigma-
Aldrich) as described [29]. Vector TRCN0000050127 was used for
depletion of ATP8B1; vector TRCN0000159317 was used for depletion
of CDC50A. All experiments were performed on cells grown on micro-
porous polycarbonate membrane ﬁlters (12 mm diameter Transwell,
0.4 μm pore size, Corning) or on polystyrene tissue culture plates
(Corning) at 3 weeks post-conﬂuency (at least 4 weeks after seeding).
Cells were used not more than 10 passages after lentiviral transduction
atwhich point theywere found to have a similar knockdown to those of
earlier passages.
2.3. Quantitative RT-PCR
Total RNA was isolated using Trizol (Invitrogen). cDNA was synthe-
sized with an oligo-dT primer and Superscript III RT (Invitrogen). RT-
PCR was performed in a Lightcycler 480 (Roche) with SYBR-Green
master mix (Roche). Expression levels were calculated with the
LinregPCR program [30] using acidic ribosomal phosphoprotein P0
(36B4) as a reference gene. Primer sequences are available on request.
2.4. Cell surface biotinylation
Cells were washed with ice-cold phosphate buffered saline contain-
ing 1mMMgCl2/0.1mMCaCl2 (PBS-CM) and incubated 2× 30minwith
1 mg/ml sulfo-NH-ss biotin (Thermo-Scientiﬁc) in ice-cold borate buff-
er (10 mM borate, 137 mM NaCl, 3.8 mM KCl, 0.9 mM CaCl2, 0.52 mM
MgCl2, 0.16 mM MgSO4 pH9.0). To quench non-bound biotin, cells
were washed twice with PBS-CM containing 100 mM glycine for
5 min. Cells were lysed in RIPA buffer (50 mM Tris–HCl, pH8.0,
150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS) containing
protease inhibitor cocktail (Roche). Biotinylated protein was precipitat-
edwith neutravidin agarose resin (Thermo-Scientiﬁc) overnight at 4 °C.
Beads were extensively washed with RIPA buffer. Biotinylated proteinwas eluted with SDS-containing sample buffer. Samples were analyzed
by SDS-PAGE and Western blotting.
2.5. Biotinylation pulse-chase assay
Cells were washed four timeswith ice-cold PBS-CM and biotin bind-
ing sites were blocked on ice with 1.5 mg/ml NHS-acetate (Thermo-
Scientiﬁc) in PBS-CM for two times 45 min. Cells were washed twice
with ice-cold PBS-CM containing 100 mM glycine for 10 min and were
incubated at 37 °C in Hanks' balanced salt solution (HBSS; Lonza) for
the indicated periods. Biotinylated proteins were isolated and detected
as described above.
2.6. SDS-PAGE and Western blotting
Proteins were separated on a poly-acrylamide gel and transferred to
a polyvinylidene diﬂuoride (Immobilon-P) membrane. Membranes
were blocked for 1 h in PBS/0.05% Tween-20 containing 4% low-fat
milk (Nutricia Proﬁtar-plus) (block buffer) and incubated for 1 h with
primary antibodies in block buffer and 1 h with HRP-conjugated
secondary antibodies (Bio-Rad) in PBS/0.05% Tween-20. After antibody
incubations, blots were extensively washed in PBS/0.05% Tween-20.
Immune complexes were visualized with Lumi-Light Western Blotting
Substrate (Roche). Chemiluminescence was detected and quantiﬁed
with a Lumi-Imager F1 and LumiAnalyst 3.1 software (Roche).
2.7. Co-immunoprecipitation
Cells were washed with ice-cold PBS, scraped into suspension,
centrifuged and resuspended in hypotonic lysis buffer (1 mM NaHCO3
supplemented with protease inhibitors) on ice for 30 min. Cells were
pestle-homogenized (30×, tight pestle) and spun down. The superna-
tant was centrifuged for 1 h at 45,000 rpm (Ti70 rotor) in an Optima
L-90K ultracentrifuge (Beckman/Coulter). The membrane pellet was re-
suspended in RIPA buffer. The membrane lysates was precleared with
Protein G sepharose 4 fast ﬂow beads (GE Healthcare) and goat-serum
IgG for 1 h at 4 °C. Cleared supernatants were incubated overnight
at 4 °C with afﬁnity-puriﬁed anti-CDC50A antibody or control IgG.
CDC50A-associated protein was immunoprecipitated by Protein G
sepharose incubation for 2 h at 4 °C. Beads were extensively washed
with RIPA buffer and immunoprecipitates were eluted with 1% SDS-
containing sample buffer. Samples were analyzed by SDS-PAGE and
Western blotting.
2.8. Taurocholate uptake assays
Caco-2 cells were incubated at 37 °C with 1 μCi/ml [3H]-[G]-
taurocholate (Perkin Elmer) in incubation buffer (143mMNaCl or cho-
line chloride (in case of sodium-free buffer), 5.4 mMKCl, 1.3 mM CaCl2,
0.4 mM MgSO4, 0.5 mM MgCl2, 0.44 mM KH2PO4, 10 mM Tris-HEPES,
pH7.4, 5.4 mM D-glucose) supplemented with 20 μM taurocholate
(Calbiochem). Cells were washed with PBS and lysed in RIPA buffer
and radioactivity was counted in a Packard Tri-carb 2900TR Liquid
Scintillation Analyzer (GMI).
2.9. 2,4-Dinitrophenyl-S-glutathione (DNP-GS) excretion assay
DNP-GS excretion, as a measure of ABCC2 activity, was determined
as described [31]. Brieﬂy, Caco-2 cells were incubated at 37 °C from
the apical and the basolateral compartmentwith the hydrophobic com-
pound 0.5 μCi/ml [14C]-labeled 1-chloro-2,4-dinitrobenzene (CDNB;
GE/Healthcare) in HBSS supplemented with 20 mM Tris-buffered
HEPES, pH 7.4. Samples were taken at the indicated time points and
were extracted with ethylacetate to separate the hydrophobic CDNB
from its hydrophilic metabolite DNP-GS. Radioactivity was measured
by liquid-scintillation counting.
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Twenty-four hour stool collections were obtained from 15 Amish
PFIC1 patients with documented ATP8B1mutation (p.G308V homozy-
gotes) amongwhom six had undergone LTx, six had undergone external
BD and three had received no surgical treatment. Twenty-four hour stool
collections from 20 healthy, age-matched controls were obtained in
The Netherlands. The study was approved by the AMC medical ethical
committee. Informed consent was obtained from all parents of partici-
pating children and from all adult participants.2.11. Fecal bile salt and electrolyte measurements
Bile saltswere extracted from feces according to themethod of Bligh
and Dyer [32]. Fecal bile salts were determined in the extracted super-
natant by reverse-phase high-performance liquid chromatography
(HPLC) [33]. Electrolytes and glucose concentrations were measured
in fecal ﬂuid by routine clinical chemistry procedures. Stool osmotic
gap (expressed in mOsmol/kg) calculations were performed according
to Binder [34] using the following equation: 290− 2 ∗ ([Na+]stool +[K
+]stool), in which 290 is the fecal ﬂuid osmolality reference value
(mOsmol/kg) [35] and [Na+]stool and [K+]stool themeasured fecal sodium
and potassium concentrations (in mM).2.12. Statistics
Data are expressed as mean± SD and were generated with Prism 5
(Graphpad). Statistical signiﬁcance was determined by performing
Student's t-test or one-way ANOVA with Bonferroni's correction for
multiple testing as indicated in the legend of the ﬁgures.Fig. 1.ATP8B1-depletedCaco-2 cells display strongly reducedATP8B1expressionwithout loss o
Caco-2 cells (n=4). Data are normalized for 36B4. Statistical signiﬁcance determined by Studen
by immunoblotting for ATP8B1 and ATP1A1 (loading control). Six different isolations are sho
and ATP8B1-depleted Caco-2 cells. N; nucleus, mp; microporous membrane. Bar represents 5
cells (n = 4). Data are normalized for 36B4.3. Results
3.1. SLC10A2-mediated taurocholate uptake is impaired in
ATP8B1-depleted Caco-2 cells
To study the consequences of ATP8B1 deﬁciency for bile salt trans-
port, we constructed ATP8B1-depleted Caco-2 cells by lentiviral trans-
duction and compared them with cells transduced with a scrambled
shRNA control (Fig. 1A, B). ATP8B1-depleted cells displayed normal
growth and differentiation, the latter evidenced by the presence of
apical microvilli (Fig. 1C). Quantitative RT-PCR analyses revealed no
signiﬁcant changes between control and ATP8B1-depleted cells for
SLC10A2 (Fig. 1D), nor for the bile salt receptor farnesoid-X receptor
(FXR) and short heterodimeric partner (SHP) (Supplementary Fig. 1).
Analysis of time-dependent taurocholate (TC) uptake revealed
that intracellular TC accumulation was strongly reduced in ATP8B1-
depleted cells (Fig. 2A). ATP8B1-depleted cells grown on Transwell
inserts displayed strongly impaired apical TC uptake, evidenced by
reduced intracellular accumulation and basolateral appearance of TC
(Fig. 2B, C). The reduced TC uptake involved a sodium-dependent
system, since replacement of sodiumby choline led to similar low levels
of TC uptake in control and knockdown cells (Fig. 2D), suggesting a
defect in SLC10A2 activity. Indeed, TC uptake was inhibited upon co-
incubation with the SLC10A2-speciﬁc inhibitor S910960 (Fig. 2E).
These results demonstrate that SLC10A2 activity is strongly impaired
in ATP8B1-depleted Caco-2 cells.
3.2. Apical membrane expression and insertion of SLC10A2 are strongly
reduced in ATP8B1-depleted Caco-2 cells
Next, SLC10A2 protein expression levels were analyzed. Compared
to human ileum, SLC10A2 expression is very low in Caco-2 cells,f apicalmicrovilli. (A) Relative ATP8B1mRNA levels in shRNAcontrol andATP8B1-depleted
t's t-test. **p b 0.01 (B) Total cell lysates of control or ATP8B1-depleted cells were analyzed
wn. (C) Transmission electron microscopical images of Transwell-grown shRNA control
μm. (D) Relative SLC10A2 mRNA levels in shRNA control and ATP8B1-depleted Caco-2
Fig. 2. SLC10A2-dependent uptake of taurocholate is reduced in ATP8B1-depleted Caco-2 cells. (A) shRNA control or ATP8B1-depleted cells grown on plastic were incubated with 20 μM
taurocholate (TC) and a trace amount of [3H]TC ([3H]TC/TC) for the indicated time periods. Intracellular TC (mol/mg protein) is plotted in time. (B) Intracellular TC accumulation in
Transwell-grown Caco-2 cells 15 and 30 min after apical administration of [3H]TC/TC (n = 4). (C) TC in the basolateral medium in the experiment shown in Fig. 2B. (D) Cells grown
on plastic were incubated in the absence (cholineCl) and presence of sodium (NaCl) with [3H]TC/TC for 30 min. Intracellular accumulation of TC is plotted (n= 5). (E) Competitive inhi-
bition of bile salt uptake by the SLC10A2-speciﬁc inhibitor S910960 (100 μM) in cells grown on plastic (n= 3). Cells were incubated for 30minwith [3H]TC/TC. Intracellular accumulation
of TC is plotted. Statistical signiﬁcance determined by Student's t-test. *p b 0.05, ***p b 0.001.
2381V.A. van der Mark et al. / Biochimica et Biophysica Acta 1842 (2014) 2378–2386appearing as two bands on a Western blot (Fig. 3A). These likely
represent the core- and terminal-glycosylated forms of the protein
[36]. Membrane-associated SLC10A2 was quantiﬁed by cell surface
biotinylation. Whereas total SLC10A2 expression was not affected,
membrane-associated SLC10A2 was hardly detectable in ATP8B1-
depleted cells (Fig. 3B). The expression level of the ER resident calnexin
was assessed as a control for proper surface biotinylation. Apparently,
biotin could pass the tight junctions since the basolateral membrane
resident ATP1A1 was also detected in the biotinylated fraction.
Next, we quantiﬁed the re-appearance of SLC10A2 on the apical
membrane by a biotinylation approach. First, biotin binding sites on
surface proteins were blocked with NHS-acetate. Subsequently, cells
were chased for the indicated times to allow insertion of apical proteins
from the intracellular pool, after which the surface was labeled with
biotin. While in the control cells surface SLC10A2 expression was
completely normalized after a one-hour chase (Fig. 3C, D), we couldnot detect any increase in SLC10A2 membrane expression in ATP8B1-
depleted cells. Apparently, NHS-acetate could not pass the tight
junctions since the ATP1A1 signal was not reduced after NHS-acetate
incubation (Fig. 3C, t = 0 h). These results strongly suggest that
ATP8B1 plays an essential role in the apical delivery of SLC10A2.
3.3. Apical organic anion excretion is unaffected in ATP8B1-depleted
Caco-2 cells
To determine if ATP8B1 depletion caused a more general defect in
apical membrane protein function, we examined the activity of multi-
drug resistance-associated protein 2 (ABCC2/MRP2), an apical protein
involved in the secretion of anionic compounds, in cells grown on
Transwell inserts. Measurement of apically secreted DNP-GS showed
that ABCC2 activity was not affected in ATP8B1-depleted Caco-2 cells
(Fig. 4).
Fig. 3. Apical membrane expression and insertion of SLC10A2 is strongly reduced in ATP8B1-depleted Caco-2 cells. (A) Cell lysates of Chinese Hamster Ovary (CHO) cells, Caco-2 cells and
human ileum were immunoblotted for SLC10A2. (B) Total cell lysates and biotinylated surface fractions of shRNA control and ATP8B1-depleted Caco-2 cells were analyzed by immuno-
blotting for SLC10A2. ATP1A1 and calnexinwere included as loading- and biotinylation control, respectively. Quantiﬁcation of SLC10A2 protein expression is includednext to its respective
blot. (C) Biotinylation sites on membrane proteins were blocked with NHS-acetate. Cells were subsequently incubated at 37 °C for the indicated time periods (t = 0, 1, 2 h) and then in-
cubated with biotin for 1 h on ice, after which cells were harvested and analyzed by immunoblotting for SLC10A2 and ATP1A1. (D) Quantiﬁcation of reappearance of SLC10A2 (n = 3).
Statistical signiﬁcance was determined by a Student's t-test. ***p b 0.001.
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Using an over-expression approach, we and others have previously
shown that CDC50A and ATP8B1 heterodimerize [3,8,9]. We analyzed
whether endogenous CDC50AandATP8B1were present as a heterodimer
in Caco-2 cells. CDC50Awas immunoprecipitated from crudemembranes
using afﬁnity-puriﬁed CDC50A antibody and the immunoprecipitates
were analyzed for the presence of ATP8B1 by Western blotting
(Fig. 5A). ATP8B1did not co-immunoprecipitatewith a rabbit IgG control
antibody. However, ATP8B1 was co-immunoprecipitated in CDC50A
immunoprecipitates, demonstrating that in Caco-2 cells endogenous
CDC50A and ATP8B1 are present as a heterodimer.Fig. 4. Apical ABCC2-mediated organic anion excretion is unaffected in ATP8B1-depleted
Caco-2 cells. Transwell-grown shRNA control and ATP8B1-depleted cells were incubated
with CDNB. At indicated time points samples were taken and extracted with ethylacetate
to separate [14C]CDNB from its metabolite [14C]DNP-GS. Apical secretion of DNP-GS is
plotted in time.
Fig. 5. ATP8B1 and CDC50A exist as a functional heterodimer in Caco-2 cells. (A) ATP8B1
was co-immunoprecipitated with afﬁnity-puriﬁed antibody to CDC50A from Caco-2
crude membrane fractions. ip; immunoprecipitates, ft; ﬂow through. Two different
concentrations of anti-CDC50A serumwere used. Rabbit IgGs were included as a negative
control. (B) shRNA control and CDC50A-depleted cells grown on plastic were incubated
with [3H]TC/TC for the indicated time periods. Intracellular TC is plotted in time. Statistical
signiﬁcance was determined by a Student's t-test. ***p b 0.001.
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bile salt uptake in CDC50A-depleted cells. Indeed, and analogous to
ATP8B1-depleted cells, TC accumulation was signiﬁcantly reduced in
CDC50A-depleted cells (Fig. 5B). In linewith this, plasmamembrane ex-
pression of both ATP8B1 and SLC10A2was strongly reduced in CDC50A-
depleted cells (Fig. 6). Intriguingly, surface expression of other apical
residents, including CD13, CD26, ABCC2 and P-glycoprotein, was not
affected in ATP8B1- and CDC50A-depleted cells. These data indicate
that the ATP8B1–CDC50A heterodimer is essential in the apical delivery
of SLC10A2 protein.
3.5. PFIC1 patients have a secretory diarrhea
Our in vitro ﬁndings supported us in hypothesizing that intestinal
bile salt malabsorption is a major determinant of diarrhea in PFIC1/
BRIC1 patients. Based on this hypothesis, we expect increased fecal
bile salt losses, especially after LTx, when diarrhea usually is aggravated.
We determined bile salt content in 24-hour stool samples of 15 PFIC1
patients of whom six had undergone LTx, six external BD and three
had received no surgical treatment. All LTx patients and two BD patients
had (semi-)liquid stools. Four BD patients, all untreated patients and all
age-matched, healthy controls had solid stools. Two LTx patients and
one BD patient received anti-diarrhetic treatment with clonidine (an
α2 adrenergic agonist that prolongs intestinal transit time to facilitate
greater absorption [37,38]), however, their stools were still (semi-)
liquid in appearance. We analyzed bile salt, glucose and electrolyte
contents and plotted this to the different treatments (Fig. 7). Although
fecal bile salt output tended to be higher in the LTx group, this only sig-
niﬁcantly differed from the BD group (Fig. 7A). Fecal glucose outputwas
also unaffected (Fig. 7B). However, fecal sodium (Fig. 7C) and chloride
(Fig. 7D) concentrations were signiﬁcantly increased whereas potassi-
um (Fig. 7E) was signiﬁcantly decreased in the LTx group compared to
the other groups. Sodium (but not chloride) was also mildly elevated
in the BD and untreated PFIC1 patients compared to healthy controls
(Fig. 7C). To analyze whether the severity of diarrhea is related to
fecal concentrations of bile salts and/or electrolytes, we graded theFig. 6. Expression of surface proteins in ATP8B1- and CDC50A-depleted Caco-2 cells.
ATP8B1-, CDC50A-depleted and shRNA control cells were biotinylated and analyzed for
expression of several apical and basolateral resident proteins. Total and surface protein
fractions are indicated. ATP1A1 and calnexin were included as loading and biotinylation
control, respectively.stools according to the Bristol stool chart [39]. These concentrations
were plotted against stool form types (Supplemental Fig. 2). Indeed,
higher fecal bile salt and electrolyte output corresponds with a higher
Bristol stool type. From the fecal ﬂuid data of the LTx patients with
diarrhea, we calculated the stool osmotic gap, an indicative value for
the cause of diarrhea. An osmotic gap below 50 mOsm/kg indicates a
secretory diarrhea while a larger osmotic gap indicates an osmotic
origin [34]. The mean osmotic gap was −4 ± 47 mOsm/kg for LTx.
These data suggest that diarrhea in PFIC1 patients is caused by intestinal
hypersecretion and/or malabsorption of electrolytes and water.
4. Discussion
Herewe show that ATP8B1 is essential for apicalmembrane localiza-
tion of the apical sodium-dependent bile acid transporter SLC10A2 in
Caco-2 cells. Little is known about trafﬁcking itineraries and regulation
of SLC10A2 in epithelial cells. Sarwar and colleagues have presented
data that suggest a regulatory role of PKC in SLC10A2 recycling; PKCζ
activation in Caco-2 cells resulted in reduced apical membrane localiza-
tion of SLC10A2 [40]. Using primary rat cholangiocytes, Alpini and co-
workers showed that SLC10A2 was recruited to the apical membrane
from intracellular stores upon stimulation with secretin [41]. In our
ATP8B1-depleted cells, strongly reduced SLC10A2 localization coincided
with unchanged total SLC10A2 protein and mRNA content, which
suggests a post-translational defect. ATP8B1 depletion thus may impair
the transport of SLC10A2 to the apical membrane. This may concern
newly synthesized SLC10A2 on its way from the TGN or recycling of
SLC10A2 between the membrane and a subapical vesicle pool. Alterna-
tively, ATP8B1 deﬁciency may interfere with the biophysical properties
of the apical membrane, leading to reduced SLC10A2 membrane
expression. We and others have previously proposed such a role for
ATP8B1 in the canalicular membrane of hepatocytes [42,43].
Chen and colleagues showed induced SLC10A2 transcript levels in
ATP8B1-depleted Caco-2 cells [44]. The authors hypothesized that
ATP8B1 deﬁciency leads to impaired FXR signaling, which leads to
reduced SHP expression and consequent induction of SLC10A2. In our
ATP8B1-depleted cells, however, none of these transcript levels were
different from control cells. One explanation for this discrepancy can
be differences in the generation of ATP8B1-depleted cell lines; Chen
and colleagues transiently depleted ATP8B1 using a siRNA approach,
whereas our study was performed in stable cell lines. Another explana-
tion can be the use of different Caco-2 cell clones and/or culture condi-
tions, which can affect morphology and function of Caco-2 cells [45]. An
essential difference, however, between the studies is that we have ana-
lyzed the consequences of ATP8B1 depletion on endogenous SLC10A2
activity, expression and localization whereas Chen and colleagues
studied ectopic SLC10A2 promoter regulation. Chen and collegues also
analyzed intestinal biopsy specimens from three PFIC1 patients and
found reduced FXR and SHP levels accompanied by induced SLC10A2
[44]. Since biopsies from two cholestatic non-PFIC1 patients did not
show elevated SLC10A2 expression, induced expression in PFIC1 sam-
ples cannot be explained by reduced luminal bile salt concentrations
as this is also expected in the non-PFIC1 patient samples. However, an
explanation for SLC10A2 induction in PFIC1 samples can be that, in
line with our present ﬁndings, SLC10A2 localization is impaired, which
results in low intracellular bile salt levels, reduced FXR signaling and
SHP expression with consequent induction of SLC10A2.
A surprising ﬁnding of our study is that, of all proteins for which
apical membrane expression was analyzed, only that of SLC10A2 apical
membrane expressionwas impaired. Verhulst and colleagues previous-
ly showed that (membrane) expression of several apical proteins,
including CD13 and alkaline phosphatase (AP), was strongly reduced
in ATP8B1-depleted Caco-2 cells [46]. Future analyses of the apical
membrane proteome should elucidate additional proteins that are
differentially expressed in ATP8B1-depleted Caco-2 cells. Along with
deﬁcient synthesis of apical proteins, Verhulst and colleagues also
Fig. 7. Fecal bile salt and electrolyte analyses are indicative for a secretory diarrhea in PFIC1 patients. 24-Hour stool samples of PFIC1 patients who had undergone liver transplantation
(LTx, six patients), biliary diversion (BD, six patients) or were not treated (NO, three patients) and age-matched, healthy controls (20 subjects) were extracted and analyzed for bile
salts. Sodium, potassium, chloride and glucose concentrations were determined in fecal ﬂuids. Patients treated with the anti-diarrhetic compound clonidine are indicated in red.
(A) Fecal bile salt excretion. (B) Glucose concentration. (C) Sodium concentrations are signiﬁcantly increased in PFIC1 LTx patients and also moderately increased in BD and NO PFIC1
patients when compared to controls. (D) Chloride concentrations are signiﬁcantly increased in LTx PFIC1 patients compared to controls and to BD and NO PFIC1 patients.
(E) Potassium concentrations are signiﬁcantly reduced in LTx PFIC1 patients when compared to controls and to BD and NO PFIC1 patients. Statistical signiﬁcance was determined by
one-way ANOVA with Bonferroni's post-hoc correction. *p b 0.05, **p b 0.01, ***p b 0.001.
2384 V.A. van der Mark et al. / Biochimica et Biophysica Acta 1842 (2014) 2378–2386described loss of microvilli, a phenotype not observed in our ATP8B1-
depleted Caco-2 cells. These discrepant ﬁndings may be attributed to
artifacts introduced by clonal selection of cells, to use of different
Caco-2 cell clones, to variation in culture conditions or to combinations
of these factors. One must note that enterocytes of ATP8B1-deﬁcient
mice do not lose microvilli (Paulusma et al., unpublished observation).
Our observation of reduced SLC10A2 activity in ATP8B1-depleted
Caco-2 cells sheds new light on the diarrhea that is observed in PFIC1
patients. The etiology of diarrhea in these patients is poorly understood.
During cholestatic periods, the intestines of PFIC1 patients encounter
reduced concentrations of bile salts. However, after restoration of bile
ﬂow, i.e. after LTx, high concentrations of bile salts enter the lumen ofthe intestine, which in combination with bile salt malabsorption may
result in spillover of bile salts to the colon and in exacerbation of diar-
rhea that can be ameliorated by application of bile salt-binding resins
[15–19]. This favors the hypothesis that intestinal bile salt malabsorp-
tion may be the underlying cause of diarrhea. Indeed, Egawa and
colleagues showed that fecal bile salt loss was increased in three of six
transplanted PFIC1 patients with diarrhea [16]. Treatment with bile
salt-binding resins improved their condition (i.e., led to normal stool
and stooling patterns), but also improved the condition of patients
without increased stool bile salt concentrations. In addition, Bijleveld
and colleagues demonstrated signiﬁcantly augmented fecal bile salt
losses in seven of 10 BRIC1 patients [47]. In our present study, all six
2385V.A. van der Mark et al. / Biochimica et Biophysica Acta 1842 (2014) 2378–2386liver-transplanted patients had diarrhea. In this small patient group
only one patient displayed elevated fecal bile salt loss. Still, our observa-
tions and those previously published strongly suggest that intestinal
bile salt malabsorption is an important determinant of PFIC1/BRIC1
diarrhea. Without access to intestinal biopsy specimens from PFIC1/
BRIC1 patients, however, it remains to be established whether apical
SLC10A2 localization is reduced in enterocytes of these patients.
In all six LTx patients, fecal sodium and chloride levels were signiﬁ-
cantly increased, while potassium levels were decreased. In case of
SLC10A2 dysfunction, spillover of bile salts to the colon will lead to
high luminal concentrations of dihydroxy bile salts, which can induce
secretion of water and electrolytes. Mekhjian and colleagues have
shown that perfusion of human large intestine with dihydroxy bile
salts such as deoxycholic acid and chenodeoxycholic acid (CDCA)
actively induces water, sodium and chloride secretion [48]. In addition,
CDCA has been shown to inhibit sodium absorption in the human colon
[49]. Thus, in PFIC1 patients, elevated colonic bile salt levels may inter-
fere with the activity of electrolyte transporters, resulting in elevated
fecal sodium and chloride concentrations.
Strikingly, the effect of ATP8B1 deﬁciency on SLC10A2 function
appears to differ importantly between man andmouse. We have previ-
ously demonstrated that, in contrast to ATP8B1-depleted Caco-2 cells,
ATP8B1-deﬁcient mice have no defect in SLC10A2 function [50]. Appar-
ently, SLC10A2 localization inmouse andhuman enterocytes is regulated
by distinct mechanisms. The mouse and human SLC10A2 sequences
deviate in the C-terminus, which was shown to be essential for apical
localization of rat SLC10A2 [51]. Alternatively, SLC10A2 localization in
mouse and man may be regulated by different P4 ATPases, or in mice
redundant activity of other P4 ATPases may compensate for the loss of
ATP8B1.
In conclusion, our results indicate that a functional ATP8B1–CDC50A
heterodimer is essential for apical membrane localization of SLC10A2 in
Caco-2 cells. Furthermore, PFIC1/BRIC1 diarrhea has a secretory origin
to which intestinal bile salt malabsorption can contribute. Whether
ileal SLC10A2 expression and activity are impaired in these patients
remains to be determined in intestinal biopsy specimens.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.09.003.
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